Surgery for Obesity and Related Diseases最新文献

英文中文

Cartoon Jan 2026 2026年1月

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.11.017

引用次数: 0

SOARD Category 1 CME Credit Featured Articles, Volume 22, January 2026 SOARD第一类CME信贷专题文章，第22卷，2026年1月

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.12.001

引用次数: 0

Does a prior conversion from adjustable gastric banding to sleeve gastrectomy impact the outcomes of subsequent conversion to Roux-en-Y gastric bypass? 先前从可调节胃束带转换为袖式胃切除术是否影响随后转换为Roux-en-Y胃旁路的结果？

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.08.024

Agustina A. Pontecorvo M.D., Jorge Cornejo M.D., Tamar Tsenteradze M.D., Steven Bowers M.D., Enrique F. Elli M.D.

Background

Adjustable gastric banding (AGB) was a widely performed bariatric surgery, but over time, sleeve gastrectomy (SG) became the most commonly performed procedure. Both AGB and SG carry the risk of weight regain, which may require conversion to Roux-en-Y gastric bypass (RYGB). However, the impact of AGB prior to SG on postoperative outcomes after conversion to RYGB remains unclear.

Objectives

The aim of this study is to compare the postoperative outcomes, including weight loss, between patients who underwent 3 bariatric procedures, including AGB, SG and finally conversion to RYGB and those who only underwent SG and conversion to RYGB.

Setting

University Hospital.

Methods

A retrospective analysis of patients who underwent SG conversion to RYGB between 2016 and 2024 was conducted. Demographics, perioperative outcomes, and weight loss were compared between patients with prior history of AGB and those without.

Results

A total of 122 patients were included, of whom 25 had AGB prior to SG conversion to RYGB. The body mass index (BMI) prior to the revision was 36.6 and 35.8kg/m², respectively. At the 2-year follow-up, data were available for 72.2% of the total cohort. There was no significant difference in operative times (P = .77) and early and late postoperative complications (P > .05). However, patients without a history of AGB demonstrated significantly greater weight loss at 6, 12, and 24 months postoperatively. Their percentage of total weight loss (%TWL) was 15.4%, 17.9%, and 19.1%, respectively, compared to 11.7%, 12.5%, and 13.3% in patients who had undergone AGB prior to SG conversion to RYGB (P = .012).

Conclusions

Patients who underwent AGB prior to other bariatric procedures tend to experience poorer weight loss compared to those who did not have prior band.

背景：可调节胃束带（AGB）是一种广泛应用的减肥手术，但随着时间的推移，袖式胃切除术（SG）成为最常用的手术。AGB和SG都有体重恢复的风险，这可能需要转到Roux-en-Y胃旁路治疗（RYGB）。然而，SG前AGB对转为RYGB后的术后结果的影响尚不清楚。目的：本研究的目的是比较接受AGB、SG并最终转化为RYGB的3种减肥手术的患者与只接受SG并转化为RYGB的患者的术后结果，包括体重减轻。单位：大学医院。方法：回顾性分析2016年至2024年间接受SG转化为RYGB的患者。比较有和无AGB病史患者的人口统计学、围手术期结局和体重减轻情况。结果：共纳入122例患者，其中25例在SG转化为RYGB之前患有AGB。修订前的身体质量指数（BMI）分别为36.6和35.8kg/m2。在2年的随访中，总队列中有72.2%的人可获得数据。两组手术次数（P = 0.77）和术后早、晚期并发症（P = 0.05）差异无统计学意义。然而，没有AGB病史的患者在术后6个月、12个月和24个月表现出明显更大的体重减轻。他们的总体重减轻百分比（%TWL）分别为15.4%、17.9%和19.1%，而在SG转化为RYGB之前接受AGB的患者为11.7%、12.5%和13.3% （P = 0.012）。结论：在其他减肥手术之前接受AGB的患者与没有接受过AGB的患者相比，体重减轻的效果更差。

{"title":"Does a prior conversion from adjustable gastric banding to sleeve gastrectomy impact the outcomes of subsequent conversion to Roux-en-Y gastric bypass?","authors":"Agustina A. Pontecorvo M.D., Jorge Cornejo M.D., Tamar Tsenteradze M.D., Steven Bowers M.D., Enrique F. Elli M.D.","doi":"10.1016/j.soard.2025.08.024","DOIUrl":"10.1016/j.soard.2025.08.024","url":null,"abstract":"<div><h3>Background</h3><div>Adjustable gastric banding (AGB) was a widely performed bariatric surgery, but over time, sleeve gastrectomy (SG) became the most commonly performed procedure. Both AGB and SG carry the risk of weight regain, which may require conversion to Roux-en-Y gastric bypass (RYGB). However, the impact of AGB prior to SG on postoperative outcomes after conversion to RYGB remains unclear.</div></div><div><h3>Objectives</h3><div>The aim of this study is to compare the postoperative outcomes, including weight loss, between patients who underwent 3 bariatric procedures, including AGB, SG and finally conversion to RYGB and those who only underwent SG and conversion to RYGB.</div></div><div><h3>Setting</h3><div>University Hospital.</div></div><div><h3>Methods</h3><div>A retrospective analysis of patients who underwent SG conversion to RYGB between 2016 and 2024 was conducted. Demographics, perioperative outcomes, and weight loss were compared between patients with prior history of AGB and those without.</div></div><div><h3>Results</h3><div>A total of 122 patients were included, of whom 25 had AGB prior to SG conversion to RYGB. The body mass index (BMI) prior to the revision was 36.6 and 35.8kg/m<sup>2</sup>, respectively. At the 2-year follow-up, data were available for 72.2% of the total cohort. There was no significant difference in operative times (<em>P</em> = .77) and early and late postoperative complications (<em>P</em> > .05). However, patients without a history of AGB demonstrated significantly greater weight loss at 6, 12, and 24 months postoperatively. Their percentage of total weight loss (%TWL) was 15.4%, 17.9%, and 19.1%, respectively, compared to 11.7%, 12.5%, and 13.3% in patients who had undergone AGB prior to SG conversion to RYGB (<em>P</em> = .012).</div></div><div><h3>Conclusions</h3><div>Patients who underwent AGB prior to other bariatric procedures tend to experience poorer weight loss compared to those who did not have prior band.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 76-83"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy 肠腔内真空治疗在套管胃切除术渗漏患者管理中的最佳营养目标。

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2026-01-01 DOI: 10.1016/j.soard.2025.08.022

Daylon A. Farias M.S. , Marc A. Ward M.D. , Brittany A. Buckmaster M.P.A.S. , Rehma Shabbir M.B.B.S. , Rachel S. Jefferies M.S. , Gerald O. Ogola Ph.D. , Santiago Quevedo B.S. , Jenifer Fang M.C.N. , Steven G. Leeds M.D.

Background

Sleeve gastrectomy is the most common bariatric procedure, and leaks from the staple line is a difficult complication to manage. Investigation into optimal nutritional support during this management is poorly studied.

Objective

The purpose of this study was to determine which supplemental nutritional group, enteral or parenteral, achieved superior nutritional outcomes.

Setting

Quaternary care center.

Methods

An IRB approved, retrospective review of a prospectively maintained database, identified patients who had a sleeve gastrectomy leak. We included patients who underwent endoluminal vacuum therapy for leak management. Patients were assigned to 3 cohorts based on their nutritional support: enteral, parenteral, or both. Primary endpoints included nutrition days, % kilocalories met, and % protein met. Secondary endpoints focused on albumin levels.

Results

A total of 28 patients (7 male, 21 female) met the inclusion criteria for the study. Five patients received enteral nutrition, 11 patients received parenteral nutrition, and 12 patients received both. Patients who received parenteral nutrition met their daily kcal and protein goals unlike patients who received enteral nutrition (97.4%% versus 55.4%, P < .01, and 105.9% versus 58.7%, P < .01, respectively). Patients who received parenteral nutrition showed an upward trend with their serum albumin levels from day 0 (3.24, 95% CI, 2.93-3.54) to Day 20 (3.34, 95%CI, 2.96-3.72).

Conclusion

Parenteral nutrition met superior goals compared to enteral nutrition. Additionally, parenteral nutrition serum albumin levels were consistently higher than enteral nutrition. Patients undergoing endoscopic therapy for gastric sleeve leak management may experience greater benefits with parenteral nutrition.

背景：袖式胃切除术是最常见的减肥手术，从钉线泄漏是一个难以处理的并发症。在这一管理过程中对最佳营养支持的调查研究很少。目的：本研究的目的是确定哪种补充营养组，肠内或肠外，获得更好的营养效果。环境：四级护理中心。方法：经IRB批准，对前瞻性维护的数据库进行回顾性审查，确定了套管胃切除术泄漏的患者。我们纳入了接受腔内真空治疗以处理泄漏的患者。患者根据营养支持分为3组：肠内、肠外或两者都有。主要终点包括营养日、满足的卡路里百分比和满足的蛋白质百分比。次要终点集中在白蛋白水平。结果：共有28例患者（男性7例，女性21例）符合研究的纳入标准。5例患者接受肠内营养，11例患者接受肠外营养，12例患者同时接受肠外营养。与接受肠内营养的患者相比，接受肠外营养的患者达到了每日卡路里和蛋白质目标（97.4%比55.4%,P < 0.01； 105.9%比58.7%,P < 0.01）。接受肠外营养的患者血清白蛋白水平从第0天（3.24,95%CI, 2.93-3.54）到第20天（3.34,95%CI, 2.96-3.72）呈上升趋势。结论：肠外营养优于肠内营养。此外，肠外营养血清白蛋白水平始终高于肠内营养。接受胃镜治疗处理胃套管漏的患者可能会体验到肠外营养更大的好处。

{"title":"Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy","authors":"Daylon A. Farias M.S. , Marc A. Ward M.D. , Brittany A. Buckmaster M.P.A.S. , Rehma Shabbir M.B.B.S. , Rachel S. Jefferies M.S. , Gerald O. Ogola Ph.D. , Santiago Quevedo B.S. , Jenifer Fang M.C.N. , Steven G. Leeds M.D.","doi":"10.1016/j.soard.2025.08.022","DOIUrl":"10.1016/j.soard.2025.08.022","url":null,"abstract":"<div><h3>Background</h3><div>Sleeve gastrectomy is the most common bariatric procedure, and leaks from the staple line is a difficult complication to manage. Investigation into optimal nutritional support during this management is poorly studied.</div></div><div><h3>Objective</h3><div>The purpose of this study was to determine which supplemental nutritional group, enteral or parenteral, achieved superior nutritional outcomes.</div></div><div><h3>Setting</h3><div>Quaternary care center.</div></div><div><h3>Methods</h3><div>An IRB approved, retrospective review of a prospectively maintained database, identified patients who had a sleeve gastrectomy leak. We included patients who underwent endoluminal vacuum therapy for leak management. Patients were assigned to 3 cohorts based on their nutritional support: enteral, parenteral, or both. Primary endpoints included nutrition days, % kilocalories met, and % protein met. Secondary endpoints focused on albumin levels.</div></div><div><h3>Results</h3><div>A total of 28 patients (7 male, 21 female) met the inclusion criteria for the study. Five patients received enteral nutrition, 11 patients received parenteral nutrition, and 12 patients received both. Patients who received parenteral nutrition met their daily kcal and protein goals unlike patients who received enteral nutrition (97.4%% versus 55.4%, <em>P</em> < .01, and 105.9% versus 58.7%, <em>P</em> < .01, respectively). Patients who received parenteral nutrition showed an upward trend with their serum albumin levels from day 0 (3.24, 95% CI, 2.93-3.54) to Day 20 (3.34, 95%CI, 2.96-3.72).</div></div><div><h3>Conclusion</h3><div>Parenteral nutrition met superior goals compared to enteral nutrition. Additionally, parenteral nutrition serum albumin levels were consistently higher than enteral nutrition. Patients undergoing endoscopic therapy for gastric sleeve leak management may experience greater benefits with parenteral nutrition.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 40-46"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

SOARD Category 1 CME Credit Featured Articles, Volume 21, December 2025 SOARD第一类CME信贷专题文章，第21卷，2025年12月

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-11-17 DOI: 10.1016/j.soard.2025.10.012

引用次数: 0

Cartoon Dec2025 卡通Dec2025

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-10-23 DOI: 10.1016/j.soard.2025.10.005

引用次数: 0

Acknowledgement of Referees 确认推荐人

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-10-14 DOI: 10.1016/j.soard.2025.09.006

引用次数: 0

SOARD Category 1 CME Credit Featured Articles, Volume 21, November 2025 SOARD第一类CME信贷专题文章，第21卷，2025年11月

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-10-14 DOI: 10.1016/j.soard.2025.09.007

引用次数: 0

Erratum to ‘Virtual care ending the stigma of obesity: insights from surgical and nonsurgical patients’ [Surgery for obesity and related diseases 21/6S (2025) pages S144-S145] “虚拟医疗结束肥胖的耻辱：来自手术和非手术患者的见解”的勘误[肥胖和相关疾病的外科21/6S（2025）页S144-S145]

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-09-24 DOI: 10.1016/j.soard.2025.08.001

Robin McDermott, Laure DeMattia Do DABFM, DABOM, Rachel Fehl MSN, RN, FNP-C, CHC, Payal Sharma DNP, MSN, RN, FNP-BC, CBN

引用次数: 0

Comment on: from disability to productivity: the impact of metabolic and bariatric surgery on return to work 点评：从残疾到生产力：代谢和减肥手术对重返工作岗位的影响。

IF 3.8 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases

Pub Date : 2025-09-24 DOI: 10.1016/j.soard.2025.09.002

Mélissa V. Wills MD, Matthew Kroh MD

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Surgery for Obesity and Related Diseases

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀